Studies on structure-function of the thyrotropin receptor : molecular biological analysis of post-translational modifications
促甲状腺素受体的结构功能研究:翻译后修饰的分子生物学分析
基本信息
- 批准号:09671064
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1. Glvcosylation of thyrotropin (TSH) receptor - TSH receptor ectodomain is heavily glycosylated with N-linked carbohydrates. In immunoprecipitation, two types of TSH receptor can be dctected - a precursor form with high mannose type carbohydrates and a mature protein with complex type carbohydrates. Using a glycosylation inhibitor tunicamycin and a series of mutant CHO cells (CHO-Lec) defective in the different steps of glycosylation processing, we found that acquisition of carbohydrates is essential for proper folding of TSH receptor in endoplasmic reticulum and its processing is involved in cell surface targeting in Golgi apparatus.2. Acylation of TSH receptor - We demonstrate a cysteine residue at amino acid 699 of the C-terminal cytoplasmic tail of the receptor is palmitoylated. Stuides with a mutant TSH receptor lacking palmitoylationreveal that palmitoylation plays a pivotal role in intracellular trafficking of the receptor, but not in high affinity TSH binding, Gs coupling, homologous desensitization or internalization.3. Subunit structure of TSH receptor - TSH receptor is well known to cleave into two subunits, A and B.However, we found that there may be two cleavage sites, releasing not only two subunits but also a small peptide (-7-8 kDa). Even extensive mutagenesis studies around possible cleavage sites failed to identify the exact cleavage site, suggesting proteolytic enzyme(s) may recognize the specific three dimensional structure, not specific amino acids, of the receptor.
1.促甲状腺激素(TSH)受体的糖基化- TSH受体胞外域被N-连接的碳水化合物严重糖基化。在免疫沉淀中,可以检测到两种类型的TSH受体-具有高甘露糖型碳水化合物的前体形式和具有复合型碳水化合物的成熟蛋白。利用糖基化抑制剂衣霉素和一系列糖基化加工缺陷的突变CHO细胞(CHO-Lec),我们发现糖基化的获得对于内质网中TSH受体的正确折叠是必不可少的,并且其加工参与高尔基体的细胞表面靶向.促甲状腺激素受体的酰化-我们证明了在受体的C-末端胞质尾的氨基酸699处的半胱氨酸残基是棕榈酰化的。对缺乏棕榈酰化的突变型TSH受体的研究表明,棕榈酰化在受体的胞内转运中起关键作用,但在高亲和力TSH结合、Gs偶联、同源脱敏或内化中不起作用. TSH受体的亚基结构-众所周知,TSH受体切割成两个亚基,A和B。然而,我们发现可能有两个切割位点,不仅释放两个亚基,而且释放一个小肽(~ 7 - 8 kDa)。即使围绕可能的切割位点进行广泛的诱变研究也未能鉴定出确切的切割位点,这表明蛋白水解酶可能识别受体的特定三维结构,而不是特定的氨基酸。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takeshi Hara: "Ionizing rediation activates c-Jun NH2-terminal kinase (JNK/SAPK) via a PKC-dependent pathway in human thyroid cells." Bichemical Biophysical Research Commununications. 244(1). 41-44 (1998)
Takeshi Hara:“电离再氧化通过人甲状腺细胞中的 PKC 依赖性途径激活 c-Jun NH2 末端激酶 (JNK/SAPK)。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
永山雄二: "TSH受容体変異による機能亢進結結節" ホルモンと臨床. 45(6). 51-59 (1997)
Yuji Nagayama:“TSH 受体突变导致的过度活跃结节”《激素与临床科学》45(6) (1997)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Noboru Takamura: "A novel point mutation of uroporphyrinogen III synthase gene in congenital erythropoietic porphyria of a Japanese family." Am J Med Genet.70 (3). 299-302 (1997)
Noboru Takamura:“日本家族先天性红细胞生成性卟啉症中尿卟啉原 III 合酶基因的一种新点突变。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ting-ting Ynag: "p53 induced by ionizing radiation mediates DNA-joining activity, but not apoptosis of thyroid cells." Oncogene. 14(3). 1511-1519 (1997)
Ting-ting Ynag:“电离辐射诱导的 p53 介导 DNA 连接活性,但不介导甲状腺细胞凋亡。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Eijun Nishihara: "Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo." Endocrinology.138 (11). 4577-4583 (1997)
Eijun Nishihara:“逆转录病毒介导的单纯疱疹病毒胸苷激酶基因转导使人甲状腺癌细胞系在体外和体内对更昔洛韦和辐射敏感。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAGAYAMA Yuji其他文献
NAGAYAMA Yuji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAGAYAMA Yuji', 18)}}的其他基金
Studies on thyorid cancer pathogenesis using mouse models
利用小鼠模型研究甲状腺癌发病机制
- 批准号:
19K09028 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on thyroid autoimmunity: anti-mouse TSH receptor immune response and central tolerance in mice
甲状腺自身免疫研究:小鼠抗小鼠TSH受体免疫反应和中枢耐受
- 批准号:
15K09437 - 财政年份:2015
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on thyroid autoimmunity: anti-TSHR immune response and tolerance in mice
甲状腺自身免疫研究:小鼠抗 TSHR 免疫反应和耐受性
- 批准号:
24591368 - 财政年份:2012
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on the pathogenesis of autoimmune thyroid diseases : using genetically-engineered mice
自身免疫性甲状腺疾病发病机制的研究:利用基因工程小鼠
- 批准号:
20591099 - 财政年份:2008
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on the pathogenesis of Graves' disease and new treatment using our recently established mouse model.
使用我们最近建立的小鼠模型研究格雷夫斯病的发病机制和新的治疗方法。
- 批准号:
17590965 - 财政年份:2005
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on the poathogenesis of Graves' disease and new treatment using our recently established mouse model.
使用我们最近建立的小鼠模型研究格雷夫斯病的发病机制和新的治疗方法。
- 批准号:
14571069 - 财政年份:2002
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Evaluation of the therapeutic effect of replication-competent adenovirus on thyroid carcinomas
具有复制能力的腺病毒对甲状腺癌的治疗效果评价
- 批准号:
12671090 - 财政年份:2000
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Post-translational Modification of Cx43 Regulates Myometrial Quiescence
Cx43 的翻译后修饰调节子宫肌层静止
- 批准号:
10575364 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Post-translational modification of GlyGly-Cterm Proteins
GlyGly-Cterm 蛋白的翻译后修饰
- 批准号:
10749396 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Structural basis for regulation of beta2 adrenergic receptor signaling by the dynamic post-translational modification S-palmitoylation
动态翻译后修饰S-棕榈酰化调节β2肾上腺素受体信号传导的结构基础
- 批准号:
10603466 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
The roles of the UFM1 post-translational modification in cellular metabolism
UFM1翻译后修饰在细胞代谢中的作用
- 批准号:
10722954 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
RUI: Simulations of MS2 spectra: An examination of post-translational modification, secondary structure, and non-covalent complexes
RUI:MS2 谱图的模拟:翻译后修饰、二级结构和非共价复合物的检查
- 批准号:
2301606 - 财政年份:2022
- 资助金额:
$ 1.98万 - 项目类别:
Standard Grant
Controlling Protein Post-translational Modification by Separating Affinity and Catalysis in Designer Enzymes
通过分离设计酶的亲和力和催化作用来控制蛋白质翻译后修饰
- 批准号:
2204094 - 财政年份:2022
- 资助金额:
$ 1.98万 - 项目类别:
Standard Grant
"Post-translational modification of non-histone proteins as a mechanism of pMHC-I neo-ligand generation"
“非组蛋白蛋白的翻译后修饰作为 pMHC-I 新配体生成的机制”
- 批准号:
10435184 - 财政年份:2022
- 资助金额:
$ 1.98万 - 项目类别:
Tumor suppressor reprogramming by EBV through post-translational modification
EBV 通过翻译后修饰重编程肿瘤抑制因子
- 批准号:
10402055 - 财政年份:2022
- 资助金额:
$ 1.98万 - 项目类别:
Post-translational modification proteomics in 4D: Chemoenzymatic tools to map the dynamic spatial organization of eukaryotic signaling pathways
4D 翻译后修饰蛋白质组学:绘制真核信号通路动态空间组织的化学酶工具
- 批准号:
10471100 - 财政年份:2022
- 资助金额:
$ 1.98万 - 项目类别:
Protein post-translational modification that regulates jasmonate biosynthesis
调节茉莉酸生物合成的蛋白质翻译后修饰
- 批准号:
573457-2022 - 财政年份:2022
- 资助金额:
$ 1.98万 - 项目类别:
University Undergraduate Student Research Awards














{{item.name}}会员




